Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability

Affordable Access

Publisher Website

Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability

Authors
Publisher
Public Library of Science
Volume
6
Issue
3
Identifiers
DOI: 10.1371/journal.pone.0018076
Keywords
  • Biology
  • Biochemistry
  • Medicine
  • Cardiovascular
  • Proteins
  • Growth Factors
  • Cell Adhesion
  • Endothelial Cells
  • Research Article
  • Peripheral Vascular Diseases
  • Cardiovascular System
  • Immunocytochemistry
  • Cadherins
  • Cell Physiology
  • Cytochemistry
  • Vascular Biology
  • Molecular Cell Biology
  • Anatomy And Physiology
  • Cellular Types
  • Cardiovascular Anatomy

Abstract

Increased vascular permeability is an early event characteristic of tissue ischemia and angiogenesis. Although VEGF family members are potent promoters of endothelial permeability the role of placental growth factor (PlGF) is hotly debated. Here we investigated PlGF isoforms 1 and 2 and present in vitro and in vivo evidence that PlGF-1, but not PlGF-2, can inhibit VEGF-induced permeability but only during a critical window post-VEGF exposure. PlGF-1 promotes VE-cadherin expression via the trans-activating Sp1 and Sp3 interaction with the VE-cadherin promoter and subsequently stabilizes transendothelial junctions, but only after activation of endothelial cells by VEGF. PlGF-1 regulates vascular permeability associated with the rapid localization of VE-cadherin to the plasma membrane and dephosphorylation of tyrosine residues that precedes changes observed in claudin 5 tyrosine phosphorylation and membrane localization. The critical window during which PlGF-1 exerts its effect on VEGF-induced permeability highlights the importance of the translational significance of this work in that PLGF-1 likely serves as an endogenous anti-permeability factor whose effectiveness is limited to a precise time point following vascular injury. Clinical approaches that would pattern nature's approach would thus limit treatments to precise intervals following injury and bring attention to use of agents only during therapeutic windows.

There are no comments yet on this publication. Be the first to share your thoughts.